Percheron Therapeutics Ltd (per) Logo

Percheron Therapeutics Ltd (PER)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

PER ASX Chart

Snapshot

Percheron Therapeutics Limited (PER, formerly Antisense Therapeutics Limited), is a publicly listed biotechnology company developing and commercializing pharmaceuticals for rare diseases with unmet medical need. The company's program is ATL1102, an antisense inhibitor of the CD49d receptor, which is currently the subject of an ongoing international Phase IIb trial for non-ambulant subjects with Duchenne Muscular Dystrophy.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +0.88%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,044 of 2,385
Sector Rank 82 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies OIL / PEB / AGN
EPS -$0.016
DPS $0.00
Book Value Per Share $0.011

Broker Consensus

PER is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Top Market Index News

More News

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Melbourne VIC 3000
Website www.percherontx.com/
Registry BoardRoom
Auditor Ernst and Young
Date Listed 20 Dec 2001

Upcoming Calendar (Forecasted)

Date Event
23/08/2024 Report (Prelim)
23/08/2024 Report (Annual)
26/02/2025 Report (Interim)

Former Company Names

  • Antisense Therapeutics Limited (ANP), 03/01/2024

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

PER directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
26/09/23 Ben Price Buy +400,000 $0.071 $28,400 On-market trade
22/08/23 James Garner Issued 600,000 $0.050 $30,000 Participation in share purchase plan
22/08/23 Charmaine Gittleson Issued 600,000 $0.050 $30,000 Participation in share purchase plan
08/05/23 James Garner Buy +300,000 $0.074 $22,200 On-market trade

Director Interests

The current holdings of PER directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Charmaine Gittleson 29/11/2023 0 733,333 3,006,667 N/A
James Garner 29/11/2023 1,000,000 N/A 6,690,000 N/A
Ben Price 26/09/2023 999,805 N/A 1,000,000 N/A
Robert Moses 15/12/2021 9,090,201 0 10,000,000 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 11, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Hsbc Custody Nominees (Australia) Limited 119,049,436 14.24%
National Nominees Limited 30,000,000 3.59%
Bnp Paribas Nominees Pty Ltd Acf Clearstream 18,198,503 2.18%
Citicorp Nominees Pty Limited 16,028,900 1.92%
Mutual Investments Pty Ltd <Mitchell Family A/C> 15,363,219 1.84%
Jamplat Pty Ltd 14,250,000 1.70%
Mr Dale Anthony Reed 13,100,000 1.57%
Esarad Holdings Pty Ltd 12,300,888 1.47%
Citycastle Pty Ltd 11,688,075 1.40%
Altor Capital Management Pty Ltd <Altor Alpha Fund A/C> 11,561,929 1.38%
Mr Robert William Moses 9,000,000 1.08%
Mr Robertson Mclennan Mitchell & Mrs Karen Joy Mitchell 7,855,319 0.94%
Shared Office Services Pty Ltd <Philanne S/F A/C> 6,946,304 0.83%
Mr Jesse Gareth Hedley & Mrs Katie Louise Hedley <Ttm Family A/C> 6,175,000 0.74%
Mr Glen Stephen Hanly 6,015,005 0.72%
Mutual Investments Pty Ltd <The Mitchell Super Fund A/C> 6,000,000 0.72%
Xcelerate Trading Pty Ltd <Xcelerate Trading A/C> 5,948,298 0.71%
Mr Mark Diamond 4,893,722 0.59%
Mrs Margaret Ann Ryan & Mr Micheal Rodney Ryan 4,770,000 0.57%
Mr Colin William Macleod & Mrs Linda Elizabeth Macleod<Macleod Super Fund A/C> 4,500,000 0.54%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 155 554 512 2,001 955 4,177

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Platinum Investment Management Limited 24/04/2024 96,266,694 10.68

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
24-07-23 Platinum Investment Management Limited 111,483,140 -- 13.33

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
24-04-24 Platinum Investment Management Limited 14,488,464 12.3 10.68
16-10-23 Platinum Investment Management Limited 727,982 13.3 12.29

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
PER Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.